Dr. Mark Benjamin , MD
Specialist • Philadelphia, PA
9501 Roosevelt Blvd, Suite #208
Philadelphia, PA 191141025
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 19, 2006; this date does not establish years in practice.
-
Published CMS data list 229 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99232 — Subsequent hospital care with moderate levelof medical decision making: 132 service units.
- 99214 — Established patient outpatient office visit: 68 service units.
- 99222 — Initial hospital care with straightforward or low-level medical decision making: 29 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See the full table · Guide: How to read Medicare Part B data
-
Published CMS data list 399 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Albuterol Sulfate Hfa (Albuterol Sulfate) — 115 prescription fills, including refills.
- Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) — 101 prescription fills, including refills.
- Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) — 41 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 9 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 90% of clinicians listed under Specialist in Philadelphia, PA (2024, 13 clinicians with data). Median for this group: 1,099. Middle half: 849 to 1,326.
Fewer Medicare Part B services than 60% of clinicians listed under Specialist in Pennsylvania (2024, 508 clinicians with data). Median for this group: 404. Middle half: 130 to 1,162.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 491 in 2020 to 229 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
9501 Roosevelt Blvd
Suite #208
Philadelphia, PA 191141025
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
162 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $22,890 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $16,211 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
463 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$151,017 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2024
All general payments: $1,137.78 across 43 records.
By nature of payment
- Food and Beverage: $1,137.78 across 43 records.
Reporting-company totals (3 largest of 8)
- AstraZeneca Pharmaceuticals LP: $560.19 across 19 records.
- GlaxoSmithKline, LLC.: $182.27 across 12 records.
- HARMONY BIOSCIENCES LLC: $155.89 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2024 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Compared with the same specialty in Philadelphia and Pennsylvania
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 90% of clinicians listed under Specialist in Philadelphia, PA (2024, 13 clinicians with data). Median for this group: 1,099. Middle half: 849 to 1,326.
Fewer Medicare Part B services than 60% of clinicians listed under Specialist in Pennsylvania (2024, 508 clinicians with data). Median for this group: 404. Middle half: 130 to 1,162.
Medicare-allowed amount
A lower Medicare-allowed amount than 90% of clinicians listed under Specialist in Philadelphia, PA (2024, 13 clinicians with data). Median for this group: $66,007. Middle half: $28,052 to $130,706.
A lower Medicare-allowed amount than 60% of clinicians listed under Specialist in Pennsylvania (2024, 508 clinicians with data). Median for this group: $33,966. Middle half: $12,327 to $84,428.
Paid by Medicare
A lower Medicare payment amount than 90% of clinicians listed under Specialist in Philadelphia, PA (2024, 13 clinicians with data). Median for this group: $52,667. Middle half: $21,927 to $100,899.
A lower Medicare payment amount than 60% of clinicians listed under Specialist in Pennsylvania (2024, 508 clinicians with data). Median for this group: $25,289. Middle half: $9,232 to $62,670.
Medicare Part D prescriptions
Fewer Part D prescriptions than 60% of clinicians listed under Specialist in Philadelphia, PA (2024, 11 clinicians with data). Median for this group: 609. Middle half: 198 to 1,127.
Close to the middle for clinicians listed under Specialist in Pennsylvania (2024, 423 clinicians with data). Median for this group: 740. Middle half: 130 to 2,767.
Part D drug cost
A higher Part D drug cost than 80% of clinicians listed under Specialist in Philadelphia, PA (2024, 11 clinicians with data). Median for this group: $72,782. Middle half: $10,154 to $138,497.
Close to the middle for clinicians listed under Specialist in Pennsylvania (2024, 423 clinicians with data). Median for this group: $67,486. Middle half: $3,569 to $475,033.
110 active clinicians are listed under Specialist with a practice address in Philadelphia, PA (2,030 in Pennsylvania).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Philadelphia
1.8% of these 110 clinicians have the CMS telehealth indicator.
10% of these 110 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 53% from 491 in 2020 to 229 in 2024.
- 2020: 491
- 2021: 626
- 2022: 492
- 2023: 382
- 2024: 229
-
Medicare-allowed amount
Medicare-allowed amount decreased 50% from $45,411 in 2020 to $22,890 in 2024.
- 2020: $45,411
- 2021: $59,772
- 2022: $48,809
- 2023: $39,628
- 2024: $22,890
-
Paid by Medicare
Paid by Medicare decreased 56% from $36,763 in 2020 to $16,211 in 2024.
- 2020: $36,763
- 2021: $48,023
- 2022: $38,097
- 2023: $29,868
- 2024: $16,211
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 38% from 639 in 2020 to 399 in 2024.
- 2020: 639
- 2021: 625
- 2022: 559
- 2023: 588
- 2024: 399
-
30-day fills
30-day fills decreased 38% from 749 in 2020 to 463 in 2024.
- 2020: 749
- 2021: 755
- 2022: 658
- 2023: 689
- 2024: 463
-
Part D drug cost
Part D drug cost decreased 17% from $181,469 in 2020 to $151,017 in 2024.
- 2020: $181,469
- 2021: $215,273
- 2022: $224,385
- 2023: $220,940
- 2024: $151,017
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $905.16 in 2020 to $1,137.78 in 2024.
- 2020: $905.16
- 2021: $864.27
- 2022: $1,261.74
- 2023: $1,440.00
- 2024: $1,137.78
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2024), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2024 (payments made January 1 – December 31, 2024): 43 records totaling $1,137.78.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $106.36 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $94.44 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $76.80 |
| HARMONY BIOSCIENCES LLC |
Food and Beverage
Cash or cash equivalent
|
WAKIX | General | $48.08 |
| HARMONY BIOSCIENCES LLC |
Food and Beverage
Cash or cash equivalent
|
WAKIX | General | $45.97 |
| Harmony Biosciences Llc |
Food and Beverage
Cash or cash equivalent
|
WAKIX | General | $41.49 |
| JAZZ PHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
XYWAV | General | $39.54 |
| JAZZ PHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
XYWAV | General | $39.06 |
| JAZZ PHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
XYWAV | General | $33.17 |
| HARMONY BIOSCIENCES LLC |
Food and Beverage
Cash or cash equivalent
|
WAKIX | General | $33.05 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $32.46 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $31.81 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $31.30 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $30.82 |
| Avadel CNS Pharmaceuticals, LLC |
Food and Beverage
In-kind items and services
|
LUMRYZ | General | $28.96 |
| HARMONY BIOSCIENCES LLC |
Food and Beverage
Cash or cash equivalent
|
WAKIX | General | $28.79 |
| Avadel CNS Pharmaceuticals, LLC |
Food and Beverage
In-kind items and services
|
LUMRYZ | General | $24.56 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $22.08 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $21.68 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $21.23 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $20.38 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $20.00 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $19.74 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $18.27 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $17.85 |
(top 25 shown)
Source: CMS Open Payments, program year 2024, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
132 | 80 | $157.00 | $78.27 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
68 | 53 | $224.00 | $130.25 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
29 | 28 | $297.00 | $127.62 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Albuterol Sulfate Hfa | Albuterol Sulfate | 115 | 3,702 | $3,049.81 | 26 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 101 | 3,570 | $74,773.09 | 21 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 41 | 1,470 | $22,491.04 | — |
| Spiriva Handihaler | Tiotropium Bromide | 37 | 1,110 | $17,281.79 | — |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 30 | 1,140 | $23,519.02 | — |
| Prednisone | Prednisone | 26 | 492 | $90.15 | 16 |
| Symbicort | Budesonide/Formoterol Fumarate | 23 | 750 | $5,484.03 | — |
| Montelukast Sodium | Montelukast Sodium | 15 | 450 | $91.50 | — |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | 330 | $4,236.52 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Infectious Disease
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated April 19, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Specialists in Philadelphia
- Dr. Oung Thain, MD
- Dr. William Beatie, MD
- Dr. Neil Isdaner, MD
- Dr. David Austria, MD
- Dr. Minda Magundayao, MD
- Dr. Joseph Mussoline, MD
Mailing Address
9501 Roosevelt Blvd, Suite #208
Philadelphia, PA 191141025
Phone: 2159692300